Cerus Corporation (CERS)

CIK 0001020214 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-07-30) · 99.1
Q1-2026 8-K (2026-04-30) · 99.1
Latest FY-2025 8-K (2026-03-02) · 99.1  |  8-K (2026-01-12) · 99.1
Q3-2025 8-K (2025-11-06) · 99.1
Q2-2025 8-K (2025-08-05) · 99.1
Q1-2025 8-K (2025-05-01) · 99.1
FY-2024 8-K (2025-02-20) · 99.1  |  8-K (2025-01-13) · 99.1
Q3-2024 8-K (2024-10-30) · 99.1
Q2-2024 8-K (2024-08-01) · 99.1
Q1-2024 8-K (2024-05-02) · 99.1
FY-2023 8-K (2024-03-05) · 99.1  |  8-K (2024-01-08) · 99.1
Q3-2023 8-K (2023-11-02) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
—
Consolidated Statements of Operations
Consolidated Statements of Comprehensive Loss
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Notes
Accrued Liabilities
Available-for-sale Securities and Fair Value On Financial Instruments
Commitments and Contingencies
Cybersecurity Risk Management, Strategy, and Governance
—
Debt
Development and License Agreements
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Inventories
Leases
Nature of Operations and Basis of Presentation
—
Pay Vs Performance Disclosure
Property and Equipment, Net
—
Restructuring
Retirement Plan
—
Segment, Customer and Geographic Information
Stock-based Compensation
Stockholders' Equity
Subsequent Event
—
Summary of Significant Accounting Policies